Title: Principal Location: Paris Investment Sector: Life Sciences

Bruno Montanari is a Principal in the life sciences group, and joined Atlas Venture in 2004.    

He joined Atlas Venture from CDP Capital in Paris where he worked as Investment Manager on deals both in Europe and North America.  He began his career as an Investment Banker in the Healthcare groups of Deutsche Bank and Merrill Lynch.  

He serves on the boards of Atlas portfolio companies Cellzome, Novexel and Xytis. He also works closely with Fibrex, JenaValve and Newron Pharmaceuticals.

Bruno holds a PharmD from the Université René Descartes and a Masters in Strategic Management from HEC, France.

Boards:
Xytis